Introduction: MALT lymphoma accounts for 7-8% of all B-cell lymphomas and at least 50% of primary gastric lymphoma, with the highest incidence at between 50 and 60 years of age. Aggressive forms are rare, as are indications for multi-visceral resection. Case study:
INTRODUCTION
MALT lymphoma accounts for 7-8% of all B-cell lymphomas and at least 50% of primary gastric lymphomas, with the highest incidence between 50 and 60 years of age (1) .
Simultaneous occurrence of gastric carcinoma with omental MALT lymphoma is very rare (2) . Both primary gastric carcinoma and MALT lymphoma are thought to be associated with H. pylori infection (3) . Helicobacter pylorus is an important causative mechanism for the development of gastric MALT syndrome, with a positive rate of 90% in the early phase of gastric MALT syndrome (4) . Diagnosis should be confirmed by biopsy. Conventional pinch biopsies may miss the diagnosis, since gastric MALT can infiltrate the submucosa without affecting the mucosa (5). We report a patient with diagnosed gastric carcinoma, but the definitive diagnosis was MALT lymphoma with infiltration of the pancreas. Multivisceral resection of the stomach, pancreas and spleen was performed. 
CASE REPORT
Th e patient, 33 years old, was admitted to the tertiary hospital as biopsy had confi rmed adenocarcinoma of the stomach. Gastroscopy and biopsy were performed at a small community hospital ( Figure 1 ). She had weight loss and epigastric pain. She was Helicobacter pylori positive. CT showed thickening of the fundus and corpus wall, up to 2.7. cm, with numerous lymph nodes along the small curvature and in the peripancreatic region, up to 1.5 cm. Th ere was close contact between the changed tumorous posterior wall of the stomach and the anterior surface of the pancreas (Figure 2 ).
Th e patient was transferred to the University hospital. Neoplasm of the stomach was found that infi ltrated the body and tail of the pancreas and spleen hilum ( Figure  3 ). Infi ltration of the left crura of the diaphragm was also found, and ex tempore biopsy showed infl ammatory infi ltration, without the elements of neoplasm.
Total gastrectomy with omeentectomy, subtotal pancreatectomy and splenectomy were performed. Th e postoperative period was normal and the patient was discharged on the tenth day. Defi nitive patho-histological diagnosis confi rmed MALT lymphoma of the stomach with pancreas infi ltration, but no tumor cells were found on the spleen. Additional staining and immunohistological examination of the specimen from the community hospital showed that it was a case of the misdiagnosis of carcinoma, and the specimen also contained MALT lymphoma (Figure 4 and 5). Chemotherapy was prescribed for the patient.
DISCUSSION
MALT lymphoma frequently occurs in the stomach. For patients with MALT, systematical staging is indicat- It is obvious that this kind of analysis cannot be accomplished in a small community hospital in a poor country such as Bosnia and Herzegovina, and suspicion of MALT indicates referral to a tertiary center.
MALT lymphoma is thought to be associated with H. pylori infection (3). Helicobacter pylori infection leads to the formation of lymphoid tissue within the stomach, and lymphomagenesis (6) . T cell dependence explains the tendency of gastric MALToma to remain localized in the stomach (7) .
However, in this case pancreas infiltration was found. Although the long term risk for transformation of MALT lymphoma into the aggressive form is low (8) , this case of the aggressive form of MALT indicates the importance of systematic staging.
The US National Comprehensive Cancer Network recommends eradication of H. Pylori as the first line of treatment for H. pylori positive gastric MALT lymphoma, and radiotherapy as the second line of treatment for H. Pylori negative or refractory limphoma (9) . Surgical resection of the superficial lesion is also an option, with low morbidity, and should be followed with low doses of chemotherapy. However in this case, multivisceral resection was performed without morbidity and mortality, and should be an option in the aggressive form of MALToma.
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